Сахарный диабет – актуальная проблема современности, связанная с развитием опасных осложнений, определяющих прогноз жизни. Для достижения целевых показателей контроля углеводного обмена большое значение имеет регулярный самоконтроль гликемии со стороны пациента. Обсуждаются результаты исследований, которые продемонстрировали, что увеличение частоты самоконтроля приводит к снижению уровня гликированного гемоглобина у пациентов с сахарным диабетом. Выбор качественного глюкометра определяется простотой использования, удобством работы прибора, легкостью получения результата и достоверностью полученных результатов измерения.
Diabetes mellitus is one of the most pressing problems of our time. It is associated with development of dangerous complications that define the patient's prognosis. Regular glycemia self-control is essential for achievement of target carbohydrate metabolism parameters. Results of the studies that demonstrated that increase of frequency of self-control results in glycated hemoglobin level decrease in diabetic patients are discussed. The choice of a proper glucometer is defined by simplicity in use, user friendliness, ease of results obtaining, and accuracy of measurement results.
1. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
2. IDF atlas. 8th edition.
3. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 2009; 169 (14): 1307–16.
4. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13.
5. Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 8-й вып. М., 2017. / Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nykh sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 8-i vyp. M., 2017. [in Russian]
6. Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl 9A): 20S–6S.
7. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
8. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012; 12: 32–6. / Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Voprosy samokontrolia glikemii v praktike lecheniia sakharnogo diabeta. Handbook for Practitioners Doctors. 2012; 12: 32–6. [in Russian]
9. Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422–5.
10. Guerci B et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587–94.
11. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111 (1): 1–9.
12. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
13. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006; p. 141.
14. McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
15. Briscoe VJ, Davis SN. Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clinical Diabetes 2006; 24 (3): 115–21.
16. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
17. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012; 11: 17.
18. Контур Плюс. Руководство пользователя. Байер, 2013. / Kontur Plius. Rukovodstvo pol'zovatelia. Baier, 2013. [in Russian]
19. International Organization for Standardization. International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.
20. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57: 3169–76.
22. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
23. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
24. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
25. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose. A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–14.
26. Tourkmani AM, Alharbi TJ, Rsheed AMB et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes Metab Syndr 2018; 12 (5): 791–4.
27. Bailey T. et al. Journal of Diabetes Science and Technology. 2017; Vol. 11(4):736-743
________________________________________________
1. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
2. IDF atlas. 8th edition.
3. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 2009; 169 (14): 1307–16.
4. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13.
5. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nykh sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 8-i vyp. M., 2017. [in Russian]
6. Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl 9A): 20S–6S.
7. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
8. Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Voprosy samokontrolia glikemii v praktike lecheniia sakharnogo diabeta. Handbook for Practitioners Doctors. 2012; 12: 32–6. [in Russian]
9. Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422–5.
10. Guerci B et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587–94.
11. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111 (1): 1–9.
12. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
13. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006; p. 141.
14. McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
15. Briscoe VJ, Davis SN. Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clinical Diabetes 2006; 24 (3): 115–21.
16. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28 (12): 2948–61.
17. Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012; 11: 17.
18. Kontur Plius. Rukovodstvo pol'zovatelia. Baier, 2013. [in Russian]
19. International Organization for Standardization. International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.
20. Caswell M, Frank J, Viggiani MT et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther 2015; 3: 1–7.
21. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008; 57: 3169–76.
22. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
23. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
24. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
25. Schnell O, Hanefeld M, Monnier L. Self-Monitoring of Blood Glucose. A Prerequisite for Diabetes Management in Outcome Trials. J Diabetes Sci Technol 2014; 8 (3): 609–14.
26. Tourkmani AM, Alharbi TJ, Rsheed AMB et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes Metab Syndr 2018; 12 (5): 791–4.
27. Bailey T. et al. Journal of Diabetes Science and Technology. 2017; Vol. 11(4):736-743
Авторы
Е.В.Бирюкова*1, Р.Г.Аскерханов2
1 ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1;
2 ГБУЗ «Московский клинический научно-практический центр им. А.С.Логинова» Департамента здравоохранения г. Москвы. 111123, Россия, Москва, ш. Энтузиастов, д. 86
*lena@obsudim.ru
________________________________________________
E.V.Biriukova*1, R.G.Askerkhanov2
1 A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1;
2 A.S.Loginov Moscow Clinical Scientific Practical Center of the Department of Health of Moscow. 111123, Russian Federation, Moscow, sh. Entuziastov, d. 86
*lena@obsudim.ru